Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate i...

Por Mikah, Phillip, Krabbe, Laura-Maria, Eminaga, Okyaz, Herrmann, Edwin, Papavassilis, Philipp, Hinkelammert, Reemt, Semjonow, Axel, Schrader, Andres-Jan, Boegemann, Martin
Publicado no BMC Cancer (2016)

Systemic therapy in metastatic renal cell carcinoma

Por Bedke, Jens, Gauler, Thomas, Grünwald, Viktor, Hegele, Axel, Herrmann, Edwin, Hinz, Stefan, Janssen, Jan, Schmitz, Stephan, Schostak, Martin, Tesch, Hans, Zastrow, Stefan, Miller, Kurt
Publicado no World J Urol (2016)

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

Por Wulfken, Lena M., Moritz, Rudolf, Ohlmann, Carsten, Holdenrieder, Stefan, Jung, Volker, Becker, Frank, Herrmann, Edwin, Walgenbach-Brünagel, Gisela, von Ruecker, Alexander, Müller, Stefan C., Ellinger, Jörg
Publicado em 2011

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study

Por Bergmann, Lothar, Kube, Ulrich, Doehn, Christian, Steiner, Thomas, Goebell, Peter J, Kindler, Manfred, Herrmann, Edwin, Janssen, Jan, Weikert, Steffen, Scheffler, Michael T, Schmitz, Joerg, Albrecht, Michael, Staehler, Michael
Publicado no BMC Cancer (2015)

Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients

Por Ciarimboli, Giuliano, Lancaster, Cynthia S., Schlatter, Eberhard, Franke, Ryan M., Sprowl, Jason A., Pavenstädt, Hermann, Massmann, Vivian, Guckel, Denise, Mathijssen, Ron H. J., Yang, Wenjian, Pui, Ching-Hon, Relling, Mary V., Herrmann, Edwin, Sparreboom, Alex
Publicado em 2012